Phytochemical Name : Antrodia cinnamomea extract

Properties Information
PhytoCAT-ID PhytoCAT-1901
Phytochemical name or plant extracts Antrodia cinnamomea extract
PMID 28602756
Literature evidence We also established an association between the CSC-inhibitory effect of A. cinnamomea and significant downregulation of several microRNAs and cancer stemness expression levels in brain and breast CSCs.
IUPAC name NA
Phytochemicals’ class or type of plant extracts Ethyl acetate extract
Source of phytochemicals or plant Extracts Antrodia cinnamomea
Geographical availability NA
Plant parts Fruiting body
Other cancers Breast cancer, Glioma, Leukemia, Lung cancer , Liver cancer, Colorectal cancer
Target gene or protein skp2
Gene or Protein evidence Suppresses the mRNA expression of skp2 (S-phase kinase-associated protein 2) by increasing the expressions of miR-21-5p, miR-26-5p, and miR-30-5p (MCF-7 and tamoxifen-resistant MCF-7 cells)
Target pathways PI3K/Akt/mTOR signaling pathway inducing apoptosis and attenuated T47D BC cell, it can suppress the mRNA expression of skp2 (S-phase kinase-associated protein 2) pathway.
IC50 NA
Potency We demonstrate the putative role of A. cinnamomea as an effective ethnopharmacologic therapeutic agent for cancer treatment.
Cell line/ mice model GBM 8401, A549, THP-1, HepG2, SW620, MDA-MB-231, HS68, 3T3, BALB/c , tamoxifen-resistant MCF-7, T47D BC cell.
Additional information  Downregulates a panel of onco-microRNAs including hsa-miR-216a, hsa-let-7e, hsamiR-221, hsa-miR-302c and hsa-miR-21 Increases the cell antioxidant ability by improving the activity of superoxide dismutase (SOD) and decreases Dox-induced ROS, has synergistic effects with Dox against MCF-7 breast cancer cells suppresses the mRNA expression of skp2 (S-phase kinase-associated protein 2) by increasing the expressions of miR-21-5p, miR-26-5p, and miR-30-5p (MCF-7 and tamoxifen-resistant MCF-7 cells)
PubChem ID NA
Additional PMIDs 25542609 28160860 29743060 25658913 32629666
Additional sources of information NA
Safety NA